Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Phase 2 Recruiting
160 enrolled
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Phase 1 Recruiting
60 enrolled
IMGeS
Phase 2 Recruiting
82 enrolled
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Phase 3 Recruiting
486 enrolled
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Phase 2 Recruiting
100 enrolled
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Phase 1/2 Recruiting
40 enrolled
MoonRISe-3
Phase 3 Recruiting
220 enrolled
Phase II Trial of Lung Chemoemobolization
Phase 2 Recruiting
30 enrolled
HIPEC-PMP
Phase 3 Recruiting
176 enrolled
Adaptive Radiation in Anal Cancer
Phase NA Recruiting
20 enrolled
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 Recruiting
70 enrolled
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Phase 1 Recruiting
49 enrolled
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
Phase 2 Recruiting
21 enrolled
COBRA-NMIBC
Phase 4 Recruiting
272 enrolled
KANALRAD
Phase 3 Recruiting
310 enrolled
GAIN INST
Phase 2 Recruiting
34 enrolled
uTRACT
Recruiting
400 enrolled
Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
Phase 3 Recruiting
180 enrolled
CRIMI
Phase 1/2 Recruiting
50 enrolled